CTD Holdings Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
268.50
2,380.10
1,842.20
960.20
1,271.00
2,217.40
Total Accounts Receivable
99.30
81.00
55.60
124.10
92.70
117.50
Inventories
241.00
575.20
610.20
497.40
471.20
416.50
Other Current Assets
10.10
13.30
14.90
53.90
60.80
18.20
Total Current Assets
618.90
3,049.50
2,522.90
1,635.50
1,895.80
2,769.60
Net Property, Plant & Equipment
1,627.30
1,645.70
1,892.90
30.00
25.70
18.60
Long-Term Note Receivable
-
-
-
203.00
167.10
259.70
Other Assets
423.40
469.90
325.00
-
-
-
Total Assets
2,895.50
5,467.10
4,740.80
1,868.50
2,088.60
3,047.90
ST Debt & Current Portion LT Debt
56.30
794.50
737.60
-
-
Accounts Payable
142.60
120.60
257.50
342.50
943.00
Other Current Liabilities
0.00
-
-
-
-
Total Current Liabilities
198.90
915.10
995.10
342.50
943.00
Long-Term Debt
795.50
-
-
-
-
Deferred Taxes
120.00
120.00
-
-
-
Total Liabilities
1,100.40
1,097.10
995.10
342.50
943.00
Common Equity (Total)
1,795.10
4,369.90
3,745.70
1,526.00
1,145.60
Total Shareholders' Equity
1,795.10
4,369.90
3,745.70
1,526.00
1,145.60
Total Equity
1,795.10
4,369.90
3,745.70
1,526.00
1,145.60
Liabilities & Shareholders' Equity
2,895.50
5,467.10
4,740.80
1,868.50
2,088.60
Preferred Stock (Carrying Value)
-
-
-
-
0.00

About CTD Holdings

View Profile
Address
6714 NW 16th Street
Gainesvile Florida 32563
United States
Employees -
Website http://www.ctd-holdings.com
Updated 07/08/2019
CTD Holdings, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product candidates include Trappsol Cyclo, which treats Neimann-Pick Type C disease. The company was founded by C.